Microbiotica

Microbiotica is a clinical-stage biopharmaceutical company specializing in the development of precision live biotherapeutic products (LBPs). Their mission is to translate clinic-led microbiome science into transformative, life-changing medicines, specifically focusing on immuno-oncology and inflammatory bowel disease. The company leverages its powerful, proprietary microbiome profiling platform, based on clinical data, to precisely identify specific bacterial strains associated with patient outcomes and target specific patient populations.

Microbiotica has established a strong syndicate of investors and is building a robust pipeline of clinic-ready LBPs. Their lead products, MB097 and MB310, are in development for melanoma and ulcerative colitis, respectively. Microbiotica also has a robust manufacturing platform, built upon expertise in culturing anaerobic gut bacteria, allowing them to develop industrializable processes for growing and preserving bacteria. The company is committed to delivering safe and precise microbiome medicines to improve patient outcomes.

Microbiotica recognizes the need for flexible working conditions and strives to find a balance between individual needs and business requirements. While specific details about offered flexibility are not provided, the company emphasizes its commitment to equal opportunity and diversity, indicating an open and accommodating approach to employment practices.

Microbiotica provides a comprehensive benefits package that emphasizes employee well-being and inclusivity. Their modern, state-of-the-art facilities offer a great working environment, while their commitment to equal opportunity and flexible working conditions supports individual needs. They value diversity in backgrounds, knowledge, and skills, creating a supportive and rewarding workplace.

Microbiotica is a clinical-stage biopharmaceutical company dedicated to developing precision microbiome medicines, specifically live biotherapeutic products (LBPs), to revolutionize the treatment of diseases like immuno-oncology and inflammatory bowel disease. They leverage their proprietary platform, built on deep microbial culturing expertise and advanced bioinformatics, to precisely identify specific bacterial strains linked to positive patient outcomes and develop targeted therapies. Microbiotica aims to provide safe and effective microbiome medicines that improve the lives of patients with unmet medical needs.

Microbiotica fosters an inclusive and respectful work environment where individuals are valued for their unique skills and backgrounds. They strive for excellence and prioritize a safe, healthy, and supportive workplace, encouraging a positive atmosphere where everyone feels welcome and motivated. They are committed to equality and diversity, offering flexible working conditions to accommodate individual needs and promote a rewarding and caring environment for their employees.

Microbiotica values diversity and fosters an inclusive culture where individuals are treated with respect and honesty. They strive to create a safe and healthy working environment, provide high-quality employee support, and are committed to equal opportunity and recognizing the unique value of each individual's background, knowledge, and skills. They are also committed to offering flexible working conditions and finding the best fit between personal requirements and business needs.